The DOI matches its Crossref record; 177 of the 179 references it cites were found in a registry or an index.
The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality
Open accessAbstract
Accumulation of advanced glycation end products (AGEs) on nucleotides, lipids, and peptides/proteins are an inevitable component of the aging process in all eukaryotic organisms, including humans. To date, a substantial body of evidence shows that AGEs and their functionally compromised adducts are linked to and perhaps responsible for changes seen during aging and for the development of many age-related morbidities. However, much remains to be learned about the biology of AGE formation, causal nature of these associations, and whether new interventions might be developed that will prevent or reduce the negative impact of AGEs-related damage. To facilitate achieving these latter ends, we show how invertebrate models, notably Drosophila melanogaster and Caenorhabditis elegans, can be used to explore AGE-related pathways in depth and to identify and assess drugs that will mitigate against the detrimental effects of AGE-adduct development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The fundamental role of AGEs, including glycoxidation products, in human aging, but also in aging of vertebrate and invertebrate model organism has been reviewed in 2018 by Chaudhuri and colleagues [153]”
From Protein oxidation - Formation mechanisms, detection and relevance as biomarkers in human diseases (2021) · cites this paper as [153]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a growing body of evidence reveals that levels of glycoxidation products increase as a function of age in several tissues, dependent on the dietary intake and the presence of hyperglycemic conditions [152,153]”
From Protein oxidation - Formation mechanisms, detection and relevance as biomarkers in human diseases (2021) · cites this paper as [153]
The cited source says what the claim attributes to it.
In the citing paper
“together indicating the relevance of AGEs as biomarkers of aging and age-related diseases”
From Protein oxidation - Formation mechanisms, detection and relevance as biomarkers in human diseases (2021) · cites this paper as [153]
In the citing paper
“However, under pathological conditions, RAGEs can be upregulated and participate in various aging-related pathophysiologies, such as adult-onset type 2 diabetes mellitus (DM), cardiovascular disorders, myocardial infarction, chronic kidney failure, pancreatitis, cancer, Alzheimer’s disease (AD), Parkinson’s disease (PD), hepatic fibrosis, and alcohol-mediated tissue injury37,38.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [37]
In the citing paper
“Generally, RAGEs are expressed widely in various cells, such as endothelial cells, macrophages/monocytes, neutrophils, lymphocytes, microglia, astrocytes, and neurons, and organs, such as the brain, heart, lung, kidney, and liver36,37.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ma, H., Li, S., Xu, P., Babcock, S. A., Dolence, E. K., Brownlee, M., Li, J., & Ren, J. T. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00547.x · Cited by 154
RetractedLópez-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107 · cited 1×
“…anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Diabetic macroangiopathy The detoxification of α-DCs, a precursor of AGE, also underlies the prevention of diabetesmediated micro and macro vascular damage that may contribute to atherosclerosis and stroke (Brownlee, 2001, 2005).”
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339 · cited 3×
“…anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Diabetic macroangiopathy The detoxification of α-DCs, a precursor of AGE, also underlies the prevention of diabetesmediated micro and macro vascular damage that may contribute to atherosclerosis and stroke (Brownlee, 2001, 2005).”
BackgroundGupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Franceschi, C., & Campisi, J. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu057 · Cited by 3,891
Advanced Glycation End Products and Diabetic Complications
Singh, V. P., Bali, A., Singh, N., & Jaggi, A. S. (2014) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2014.18.1.1 · Cited by 1,518
The use of animal models in diabetes research
King, A. J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01911.x · Cited by 1,303 · cited 1×
“Vertebrate model organisms such as rodents are a natural first choice to model AGEmediated pathologies, due to the relatively close link to human disease biology and a track record as a model for studying disease pathology in diabetes (King, 2012).”
BackgroundAminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking
Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P. C., & Cerami, A. (1986) · Science · doi:10.1126/science.3487117 · Cited by 1,146
Structure Elucidation of a Senescence Cross-Link from Human Extracellular Matrix
Sell, D. R., & Monnier, V. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88225-8 · Cited by 1,082
Basta, G. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.05.001 · Cited by 1,018
Schmidt, A. M., Hori, O., Chen, J. X., Li, J. F., Crandall, J., Zhang, J., Cao, R., Yan, S. D., Brett, J., & Stern, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118175 · Cited by 896
Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB
Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P. M., Chen, J., Hong, M., Luther, T., Henle, T., Klöting, I., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2792 · Cited by 826
Thornalley, P. J. (1990) · Biochemical Journal · doi:10.1042/bj2690001 · Cited by 819 · cited 1×
“The glyoxalase system can be either glutathione GSH-dependent (e.g., Glo1) or GSH-independent (e.g., Dj-1) (Lee et al., 2012; Thornalley, 1990).”
BackgroundClements, C. M., McNally, R. S., Conti, B. J., Mak, T. W., & Ting, J. P.-Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607260103 · Cited by 818
Advanced glycation end products contribute to amyloidosis in Alzheimer disease
Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Advanced glycoxidation end products in commonly consumed foods
Goldberg, T., Cai, W., Peppa, M., Dardaine, V., Baliga, B. S., Uribarri, J., & Vlassara, H. (2004) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.05.214 · Cited by 744
Lo, T. W. C., Westwood, M. E., McLellan, A. C., Selwood, T., & Thornalley, P. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31635-1 · Cited by 695
Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts
Thornalley, P. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.013 · Cited by 691 · cited 1×
“Unfortunately, the trial was discontinued due to side effects (Thornalley, 2003), which has led to reduced enthusiasm in the field that lowering AGEs would be a successful strategy in treating age-related diseases.”
BackgroundAccelerated age-related browning of human collagen in diabetes mellitus.
Monnier, V. M., Kohn, R. R., & Cerami, A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.2.583 · Cited by 672
Thornalley, P. J., Battah, S., Ahmed, N., Karachalias, N., Agalou, S., Babaei‐Jadidi, R., & Dawnay, A. (2003) · Biochemical Journal · doi:10.1042/bj20030763 · Cited by 669 · cited 1×
“Unfortunately, the trial was discontinued due to side effects (Thornalley, 2003), which has led to reduced enthusiasm in the field that lowering AGEs would be a successful strategy in treating age-related diseases.”
BackgroundAdvanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both?
Vlassara, H., & Uribarri, J. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0453-1 · Cited by 594
Action des acides amines sur les sucres : formation des melanoidines par voie methodique
Maillard, L. (1912) · Medical Entomology and Zoology · Cited by 574
Maillard reaction products in tissue proteins: New products and new perspectives
Thorpe, S. R., & Baynes, J. (2003) · Amino Acids · doi:10.1007/s00726-003-0017-9 · Cited by 543
Receptor for AGE (RAGE): Signaling mechanisms in the pathogenesis of diabetes and its complications
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06320.x · Cited by 521
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
Zheng, H., Whitman, S. A., Wu, W., Wondrak, G. T., Wong, P. K., Fang, D., & Zhang, D. D. (2011) · Diabetes · doi:10.2337/db11-0807 · Cited by 507
Bierhaus, A., Fleming, T. H., Stoyanov, S., Leffler, A., Babeș, A., Neacsu, C., Sauer, S. K., Eberhardt, M. J., Schnölzer, M., Lasitschka, F., et al. (2012) · Nature Medicine · doi:10.1038/nm.2750 · Cited by 500
Tanji, N., Markowitz, G. S., Fu, C., Kislinger, T., Taguchi, A., Pischetsrieder, M., Stern, D. M., Schmidt, A. M., & D’Agati, V. D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191656 · Cited by 485
Bucala, R., Makita, Z., Vega, G., Grundy, S. M., Koschinsky, T., Cerami, A., & Vlassara, H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9441 · Cited by 471
Oldfield, M. D., Bach, L. A., Forbes, J. M., Nikolic‐Paterson, D. J., McRobert, E. A., Thallas, V., Atkins, R. C., Osicka, T. M., Jerums, G., & Cooper, M. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11951 · Cited by 464
The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy
Jiang, T., Huang, Z., Lin, Y., Zhang, Z., Fang, D., & Zhang, D. D. (2010) · Diabetes · doi:10.2337/db09-1342 · Cited by 440
Studies of an unusual hemoglobin in patients with diabetes mellitus
Rahbar, S., Blumenfeld, O. O., & Ranney, H. M. (1969) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(69)90685-8 · Cited by 394
Advanced glycation end products in the pathogenesis of chronic kidney disease
Rabbani, N., & Thornalley, P. J. (2018) · Kidney International · doi:10.1016/j.kint.2017.11.034 · Cited by 387
Dietary Advanced Glycation End Products and Their Role in Health and Disease
Uribarri, J., del Castillo, M. D., de la Maza, M. P., Filip, R., Gugliucci, A., Luévano‐Contreras, C., Macías-Cervantes, M. H., Bastos, D. H. M., Medrano, A., Menini, T., et al. (2015) · Advances in Nutrition · doi:10.3945/an.115.008433 · Cited by 381
Self-citationThe RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2010) · Circulation Research · doi:10.1161/circresaha.109.212217 · Cited by 381
Vlassara, H., Fuh, H., Makita, Z., Krungkrai, S., Cerami, A., & Bucala, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12043 · Cited by 378
Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
Makita, Z., Bucala, R., Rayfield, E. J., Fuh, H., Manogue, K. R., Cerami, A., Viassara, H., Friedman, E. A., Kaufman, A. M., Korbet, S. M., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92935-1 · Cited by 376
Neuroprotective Function of DJ-1 in Parkinson’s Disease
Ariga, H., Takahashi-Niki, K., Kato, I., Maita, H., Niki, T., & Iguchi-Ariga, S. M. M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/683920 · Cited by 373
Byun, K., Yoo, Y., Son, M., Lee, J., Jeong, G.-B., Park, Y. M., Salekdeh, G. H., & Lee, B. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.030 · Cited by 357
Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease
Rabbani, N., & Thornalley, P. J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.140 · Cited by 353
Cai, W., Ramdas, M., Zhu, L., Chen, X., Striker, G. E., & Vlassara, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205847109 · Cited by 337
Analysis of microtubule-associated protein tau glycation in paired helical filaments.
Ledesma, M. D., Bonay, P., Colaço, C., & Avila, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31849-5 · Cited by 333
Uribarri, J., Peppa, Μ., Cai, W., Goldberg, T., Lu, M. M., He, C., & Vlassara, H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000051593.41395.b9 · Cited by 331
The role of AGEs in aging: causation or correlation
Baynes, J. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00138-3 · Cited by 329 · cited 1×
“The characterization of several cross-links present in collagen and their association with arterial disease has underscored their importance in diabetic complications as well as in aging (Baynes, 2001; Baynes et al., 1989; Dyer et al., 1991; Thorpe and Baynes, 2003).”
BackgroundZheng, W.-H., Bastianetto, S., Mennicken, F., Ma, W., & Kar, S. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00404-9 · Cited by 321
Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease
Castellani, R. J., Smith, M. A., Richey, G. L., & Perry, G. L. (1996) · Brain Research · doi:10.1016/0006-8993(96)00729-9 · Cited by 315
Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
Li, X., Leng, S. X., & Song, D. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s74042 · Cited by 314
Sell, D. R., Lapolla, A., Odetti, P. R., Fogarty, J. F., & Monnier, V. M. (1992) · Diabetes · doi:10.2337/diab.41.10.1286 · Cited by 310
Xue, M., Rabbani, N., Momiji, H., Imbasi, P., Anwar, M. M., Kitteringham, N. R., Park, B. K., Souma, T., Moriguchi, T., Yamamoto, M. P., et al. (2011) · Biochemical Journal · doi:10.1042/bj20111648 · Cited by 302
Rage: A Novel Cellular Receptor for Advanced Glycation End Products
Schmidt, A. M., Hori, O., Cao, R. Y., Yan, S. D., Brett, J., Wautier, J., Ogawa, S., Kuwabara, K., Matsumoto, M., & Stern, D. (1996) · Diabetes · doi:10.2337/diab.45.3.s77 · Cited by 299
Trojanowski, J. Q., Goedert, M., Iwatsubo, T., & Lee, V. M. ‐. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400432 · Cited by 297
C. elegans as Model for the Study of High Glucose– Mediated Life Span Reduction
Schlotterer, A., Kukudov, G., Bozorgmehr, F., Hutter, H., Du, X., Oikonomou, D., Ibrahim, Y., Pfisterer, F., Rabbani, N., Thornalley, P. J., et al. (2009) · Diabetes · doi:10.2337/db09-0567 · Cited by 297
An antidepressant that extends lifespan in adult Caenorhabditis elegans
Petrascheck, M., Ye, X., & Buck, L. B. (2007) · Nature · doi:10.1038/nature05991 · Cited by 290
Morcos, M., Du, X., Pfisterer, F., Hutter, H., Sayed, A. A. R., Thornalley, P. J., Ahmed, N., Baynes, J., Thorpe, S. R., Kukudov, G., et al. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00371.x · Cited by 281
Jagt, D. L. V., Robinson, B., Taylor, K. K., & Hunsaker, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42844-x · Cited by 280
Miyata, T., Hori, O., Zhang, J., Yan, S. S., Ferran, L., Iida, Y., & Schmidt, A. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118889 · Cited by 278
Richarme, G., Mihoub, M., Dairou, J., Bui, L. C., Leger, T., & Lamouri, A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.597815 · Cited by 268
Rabbani, N., & Thornalley, P. J. (2014) · Nature Protocols · doi:10.1038/nprot.2014.129 · Cited by 267
The glyoxalase pathway: the first hundred years… and beyond
Silva, M. S., Gomes, R. A., Ferreira, A. E. N., Freire, A. P., & CORDEIRO, C. A. (2013) · Biochemical Journal · doi:10.1042/bj20121743 · Cited by 263
Human DJ-1 and its homologs are novel glyoxalases
Lee, J., Song, J., Kwon, K., Jang, S., Kim, C., Baek, K., Kim, J., & Park, C. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds155 · Cited by 259
Freedman, B. I., Wuerth, J.-P., Cartwright, K. J., Bain, R. P., Dippe, S. E., Hershon, K. S., Mooradian, A. D., & Spinowitz, B. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00024-0 · Cited by 257
Gugliucci, A., & Bendayan, M. (1996) · Diabetologia · doi:10.1007/bf00403957 · Cited by 247
Self-citationLongevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence.
Sell, D. R., Lane, M. A., Johnson, W. A., Masoro, E. J., Mock, O. B., Reiser, K. M., Fogarty, J. F., Cutler, R. G., Ingram, D. K., Roth, G. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.485 · Cited by 243
Ahmed, N., Ahmed, U., Thornalley, P. J., Häger, K., Fleischer, G., & Münch, G. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02864.x · Cited by 237
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies
Miranda, H. V., Szegő, É. M., Oliveira, L. M. A., Breda, C., Darendelioğlu, E., de Oliveira, R. M., Ferreira, D. G., Gomes, M. A., Rott, R., de Oliveira, M. S. D., et al. (2017) · Brain · doi:10.1093/brain/awx056 · Cited by 234
Münch, G., Lüth, H. J., Wong, A., Arendt, T., Hirsch, E., Ravid, R., & Riederer, P. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00096-x · Cited by 231
Gugliucci, A. (2017) · Advances in Nutrition · doi:10.3945/an.116.013912 · Cited by 225 · cited 3×
“Despite this accumulating evidence, debate continues over whether AGEs are causal or just a consequence of aging and age-related diseases (Gugliucci, 2017).”
BackgroundResultSelf-citationRadical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond
Daffu, G., Del Pozo, C., O'Shea, K., Ananthakrishnan, R., Ramasamy, R., & Schmidt, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141019891 · Cited by 222
Ziegler, D., Reljanović, M., Mehnert, H., & Gries, F. A. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212132 · Cited by 220
Yamagishi, S., Nakamura, K., Matsui, T., Inagaki, Y., Takenaka, K., Jinnouchi, Y., Yoshida, Y., Matsuura, T., Narama, I., Motomiya, Y., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602110200 · Cited by 217
Forbes, J. M., Thorpe, S. R., Thallas‐Bonke, V., Pete, J., Thomas, M. C., Deemer, E. R., Bassal, S., El‐Osta, A., Long, D. M., Panagiotopoulos, S., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010062 · Cited by 211
Differential accumulation of advanced glycation end products in the course of diabetic retinopathy
Hammes, H. P., Alt, A., Niwa, T., Clausen, J. T., Bretzel, R. G., Brownlee, M., & Schleicher, E. D. (1999) · Diabetologia · doi:10.1007/s001250051221 · Cited by 205
Uchiki, T., Weikel, K. A., Jiao, W., Shang, F., Caceres, A., Pawlak, D., Handa, J. T., Brownlee, M., Nagaraj, R., & Taylor, A. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2011.00752.x · Cited by 200
Uribarri, J., Peppa, Μ., Cai, W., Goldberg, T., Lu, M. M., Baliga, S. K., Vassalotti, J. A., & Vlassara, H. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00779-0 · Cited by 197
DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway
Im, J., Lee, K.-W., Woo, J.-M., Junn, E., & Mouradian, M. M. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds131 · Cited by 197
Lüth, H. J. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh123 · Cited by 192
Glycation exacerbates the neuronal toxicity of β-amyloid
Li, X.-H., Du, L.-L., Cheng, X.-S., Jiang, X., Zhang, Y., Lv, B.-L., Liu, R., Wang, J.-Z., & Zhou, X.-W. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.180 · Cited by 184
Knockdown of Glyoxalase 1 Mimics Diabetic Nephropathy in Nondiabetic Mice
Giacco, F., Du, X., D’Agati, V. D., Milne, R. W., Sui, G., Geoffrion, M., & Brownlee, M. (2013) · Diabetes · doi:10.2337/db13-0316 · Cited by 184
Glycation Products as Markers and Predictors of the Progression of Diabetic Complications
Monnier, V. M., Sell, D. R., & GENUTH, S. M. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.065 · Cited by 182 · cited 2×
“Modified from: (Monnier et al., 2005).”
BackgroundDelgado‐Andrade, C., & Fogliano, V. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030117-012441 · Cited by 177
Guanine glycation repair by DJ-1/Park7 and its bacterial homologs
Richarme, G., Cai-ling, L., Mihoub, M., Abdallah, J., Léger, T., Joly, N., Liébart, J.-C., Jurkunas, U. V., Nadal, M., Bouloc, P., et al. (2017) · Science · doi:10.1126/science.aag1095 · Cited by 174
The Amadori product on protein: structure and reactions.
Baynes, J., Watkins, N. G., Fisher, C. I., Hull, C. J., Patrick, J. S., Ahmed, M. U., Dunn, J. A., & Thorpe, S. R. (1989) · PubMed · Cited by 170
Soluble forms of RAGE in internal medicine
Vazzana, N., Santilli, F., Cuccurullo, C., & Davı̀, G. (2009) · Internal and Emergency Medicine · doi:10.1007/s11739-009-0300-1 · Cited by 170
Soluble RAGE: Therapy and biomarker in unraveling the RAGE axis in chronic disease and aging
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.013 · Cited by 169
Piperi, C., Adamopoulos, C., Dalagiorgou, G., Diamanti‐Kandarakis, E., & Papavassiliou, A. G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3408 · Cited by 169
Atherosclerosis and diabetes: The rage connection
Schmidt, A. M., & Stern, D. M. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0082-4 · Cited by 167
Role of Advanced Glycation End Products (AGEs) in Osteoporosis in Diabetes
Yamagishi, S. (2011) · Current Drug Targets · doi:10.2174/138945011798829456 · Cited by 164 · cited 2×
“Similar work has underscored the importance of AGEs in bone health with age (Yamagishi, 2011).”
BackgroundAdvanced glycation end products and diabetic complications: A General overview
Peppa, Μ., & Vlassara, H. (2005) · HORMONES · doi:10.14310/horm.2002.11140 · Cited by 152
Profound Mishandling of Protein Glycation Degradation Products in Uremia and Dialysis
Agalou, S., Ahmed, N., Babaei‐Jadidi, R., Dawnay, A., & Thornalley, P. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080635 · Cited by 150
THE CROSSLINKAGE THEORY OF AGING
Bjorksten, J. (1968) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1968.tb02821.x · Cited by 149 · cited 1×
“More than three decades ago, Monnier and Cerami proposed a Maillard theory of aging postulating that slow and continuous accumulation of AGEs was a causal factor in aging (Bjorksten, 1968; Monnier, 1989; Monnier et al., 1988; Sell and Monnier, 1989).”
BackgroundBrouwers, O., Niessen, P., Miyata, T., Østergaard, J. A., Flyvbjerg, A., Peutz‐Kootstra, C. J., Sieber, J., Mundel, P. H., Brownlee, M., Janssen, B. J., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3088-5 · Cited by 143
Toward a Maillard reaction theory of aging.
Monnier, V. M. (1989) · PubMed · Cited by 142
RAGE and the pathogenesis of chronic kidney disease
D’Agati, V. D., & Schmidt, A. M. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.54 · Cited by 136
Advanced glycation endproducts and their pathogenic roles in neurological disorders
Münch, G. W., Westcott, B., Menini, T., & Gugliucci, A. (2010) · Amino Acids · doi:10.1007/s00726-010-0777-y · Cited by 133
Self-citationChen, K., Maley, J., & Yu, P. H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04181.x · Cited by 131
Methylglyoxal Evokes Pain by Stimulating TRPA1
Andersson, D. A., Gentry, C., Light, E., Vastani, N., Vallortigara, J., Bierhaus, A., Fleming, T. H., & Bevan, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077986 · Cited by 131
Zhou, Z., Tang, Y. M., Jin, X., Chen, C., Lu, Y., Liu, L., & Shen, C. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4847812 · Cited by 127
Prevention of Diabetic Complications by Activation of Nrf2: Diabetic Cardiomyopathy and Nephropathy
Li, B., Liu, S., Miao, L., & Cai, L. (2012) · Experimental Diabetes Research · doi:10.1155/2012/216512 · Cited by 126
Guerrero, E., Vasudevaraju, P., Hegde, M. L., Britton, G. B., & Rao, K. S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8328-z · Cited by 121
Semba, R. D., Bandinelli, S., Sun, K., Guralnik, J. M., & Ferrucci, L. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02438.x · Cited by 118
Baba, S. P., Barski, O. A., Ahmed, Y., O’Toole, T. E., Conklin, D. J., Bhatnagar, A., & Srivastava, S. (2009) · Diabetes · doi:10.2337/db09-0375 · Cited by 117
Fatty Acid Synthase Cooperates with Glyoxalase 1 to Protect against Sugar Toxicity
Garrido, D., Rubin, T., Poidevin, M., Maroni, B., Rouzic, A. L., Parvy, J.-P., & Montagne, J. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004995 · Cited by 115
Tsantoulas, C., Laínez, S., Wong, S., Mehta, I. S., Vilar, B., & McNaughton, P. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam6072 · Cited by 112
Dyer, D. G., Blackledge, J. A., Katz, B. M., Hull, C. J., Adkisson, H. D., Thorpe, S. R., Lyons, T. J., & Baynes, J. (1991) · Zeitschrift für Ernährungswissenschaft · doi:10.1007/bf01910730 · Cited by 111
Kuhla, B., Boeck, K., Schmidt, A., Ogunlade, V., Arendt, T., Münch, G., & Lüth, H.-J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.11.007 · Cited by 108
Extending the Spectrum of α-Dicarbonyl Compounds in Vivo
Henning, C., Liehr, K., Girndt, M., Ulrich, C., & Glomb, M. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.563593 · Cited by 104
Glyoxalase 1 Modulation in Obesity and Diabetes
Rabbani, N., & Thornalley, P. J. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7424 · Cited by 102
Ko, S., Lin, Y.-P., Lin, Y.-S., & Chang, S.-S. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.05.005 · Cited by 101
Advanced glycation end-products and bone fractures
Vashishth, D. (2009) · IBMS BoneKEy · doi:10.1138/20090390 · Cited by 99 · cited 1×
“Several studies have addressed the buildup of AGEs in long-lived proteins (Hammes et al., 1999; Sell et al., 1992; Vashishth, 2009).”
BackgroundGlyoxal Formation and Its Role in Endogenous Oxalate Synthesis
Lange, J. N., Wood, K. D., Knight, J. L., Assimos, D. G., & Holmes, R. P. (2012) · Advances in Urology · doi:10.1155/2012/819202 · Cited by 97
Shaikh, S. B., & Nicholson, L. F. B. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21644 · Cited by 92
Rabbani, N., Sebekova, K., Sebekova, K., Heidland, A., & Thornalley, P. J. (2007) · Kidney International · doi:10.1038/sj.ki.5002513 · Cited by 90
Serum Advanced Glycosylation End Products: A New Class of Uremic Toxins?
Vlassara, H. (2008) · Blood Purification · doi:10.1159/000170145 · Cited by 88 · cited 1×
“Due to this fact, AGE adducts are one of the classical ‘middle toxins’ associated with renal failure (Vlassara, 1994).”
BackgroundNakashima, A., Carrero, J. J., Qureshi, A. R., Miyamoto, T., Anderstam, B., Barany, P. F., Heimbürger, O., Stenvinkel, P., & Lindholm, B. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03360410 · Cited by 84
Monnier, V. M., Sell, D. R., Abdul‐Karim, F. W., & Emancipator, S. N. (1988) · Diabetes · doi:10.2337/diab.37.7.867 · Cited by 83
Kalousová, M., Jáchymová, M., Mestek, O., Hodkova, M., Kazderová, M., Tesař, V., & Zima, T. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm050 · Cited by 79
Impairing L-Threonine Catabolism Promotes Healthspan through Methylglyoxal-Mediated Proteohormesis
Ravichandran, M., Priebe, S., Grigolon, G., Rozanov, L. F., Groth, M., Laube, B., Guthke, R., Platzer, M., Zarse, K., & Ristow, M. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.004 · Cited by 79
Identification of Fructosamine Residues Deglycated by Fructosamine-3-kinase in Human Hemoglobin
Delpierre, G., Vertommen, D., Communi, D., Rider, M. H., & SCHAFTINGEN, E. V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402091200 · Cited by 77
Advanced Glycation End Products in Renal Failure
Thornalley, P. J. (2006) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2006.04.012 · Cited by 72 · cited 1×
“These pathways, which depend on glomerular filtration and tubular function, are severely compromised in chronic and end-stage renal failure (Thornalley, 2005a, 2006).”
BackgroundMonnier, V. M., Sun, W., Sell, D. R., Fan, X., Nemet, I., & GENUTH, S. M. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0174 · Cited by 72
Gnerer, J. P., Kreber, R. A., & Ganetzky, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606887103 · Cited by 72
Rutkove, S. B., & McIlduff (2011) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s11325 · Cited by 71
Hipkiss, A. R., Cartwright, S. P., Bromley, C., Gross, S. R., & Bill, R. M. (2013) · Chemistry Central Journal · doi:10.1186/1752-153x-7-38 · Cited by 71
Chaudhuri, J., Bose, N., Gong, J., Hall, D., Rifkind, A., Bhaumik, D., Peiris, T. H., Chamoli, M., Le, C. H., Liu, J., et al. (2016) · Current Biology · doi:10.1016/j.cub.2016.09.024 · Cited by 71
Self-citationZheng, F., Cai, W., Mitsuhashi, T., Vlassara, H., & Bucala, R. (2001) · Molecular Medicine · doi:10.1007/bf03401963 · Cited by 70
Woltjer, R. L., Maezawa, I., Ou, J. J., Montine, K. S., & Montine, T. J. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5607 · Cited by 69
Thornalley, P. J., & Rabbani, N. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2009.00589.x · Cited by 68 · cited 1×
“…of sensitive LC-MS/MS techniques, a more comprehensive representation of the role of the kidney in AGE control emerged, including the fate of small peptides and free adducts (Agalou et al., 2005; Rabbani and Thornalley, 2009; Rabbani et al., 2007; Thornalley, 2005b; Thornalley and Rabbani, 2009).”
MethodEnhanced RAGE-mediated NFκB stimulation in inflamed hemodialysis patients
Rodríguez-Ayala, E., Anderstam, B., Suliman, M. E., Seeberger, A., Heimbürger, O., Lindholm, B., & Stenvinkel, P. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.007 · Cited by 66
Monnier, V. M., Sun, W., Gao, X., Sell, D. R., Cleary, P. A., Lachin, J. M., & GENUTH, S. M. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0266-4 · Cited by 65
Raposeiras‐Roubín, S., Rodiño‐Janeiro, B. K., Grigorian-Shamagian, L., Moure‐González, M., Seoane‐Blanco, A., Roman, A. V., Álvarez, E., & González‐Juanatey, J. R. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq117 · Cited by 62
Advanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type Mice
Sayej, W. N., Knight, P. R., Guo, W. A., Mullan, B., Ohtake, P. J., Davidson, B. A., Khan, A. R., Baker, R. D., & Baker, S. S. (2016) · BioMed Research International · doi:10.1155/2016/7867852 · Cited by 58
Chen, P., DeWitt, M. R., Bornhorst, J., Soares, F. A. A., Mukhopadhyay, S., Bowman, A. B., & Aschner, M. (2014) · Metallomics · doi:10.1039/c4mt00292j · Cited by 57
Measurement of Protein Glycation, Glycated Peptides, and Glycation Free Adducts
Thornalley, P. J. (2005) · Peritoneal Dialysis International · doi:10.1177/089686080502500603 · Cited by 57 · cited 2×
“…of sensitive LC-MS/MS techniques, a more comprehensive representation of the role of the kidney in AGE control emerged, including the fate of small peptides and free adducts (Agalou et al., 2005; Rabbani and Thornalley, 2009; Rabbani et al., 2007; Thornalley, 2005b; Thornalley and Rabbani, 2009).”
BackgroundMethodEvidence Against a Role for the Parkinsonism-associated Protein DJ-1 in Methylglyoxal Detoxification
Pfaff, D. H., Fleming, T. H., Nawroth, P. P., & Teleman, A. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.743823 · Cited by 55
Glycation free adduct accumulation in renal disease: the new AGE
Thornalley, P. J. (2005) · Pediatric Nephrology · doi:10.1007/s00467-005-2011-9 · Cited by 53 · cited 2×
“…of sensitive LC-MS/MS techniques, a more comprehensive representation of the role of the kidney in AGE control emerged, including the fate of small peptides and free adducts (Agalou et al., 2005; Rabbani and Thornalley, 2009; Rabbani et al., 2007; Thornalley, 2005b; Thornalley and Rabbani, 2009).”
BackgroundMethodGolegaonkar, S. B., Tabrez, S. S., Pandit, A., Sethurathinam, S., Jagadeeshaprasad, M. G., Bansode, S. B., Sampathkumar, S., Kulkarni, M. J., & Mukhopadhyay, A. (2015) · Aging Cell · doi:10.1111/acel.12327 · Cited by 51
Monnier, V. M., Stevens, V. J., & Cerami, A. (1981) · PubMed · Cited by 48
Jack, M. M., Ryals, J. M., & Wright, D. E. (2011) · Diabetologia · doi:10.1007/s00125-011-2196-3 · Cited by 47
Identification of glyoxalase 1 polymorphisms associated with enzyme activity
Pečulis, R., Konrāde, I., Skapare, E., Frīdmanis, D., Ņikitina-Zaķe, L., Lejnieks, A., Pīrāgs, V., Dambrova, M., & Kloviņš, J. (2012) · Gene · doi:10.1016/j.gene.2012.11.009 · Cited by 46
Gugliucci, A., & Bendayan, M. (1995) · Journal of Histochemistry & Cytochemistry · doi:10.1177/43.6.7769229 · Cited by 45
Self-citationDeng, Y., Zhang, Y., Li, Y., Xiao, S., Song, D., Qing, H., Li, Q., & Rajput, A. H. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0724-4 · Cited by 45
Xing, L. V., Lv, G., Guo-Ying, D. A. I., Sun, H., & Xu, H. (2016) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(16)30101-7 · Cited by 44
Jaramillo, R. J., Shuck, S. C., Chan, Y. S., Liu, X., Bates, S., Lim, P. P., Tamae, D., Lacoste, S., O'Connor, T. R., & Termini, J. S. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00414 · Cited by 44
Hormesis enables cells to handle accumulating toxic metabolites during increased energy flux
Zemva, J., Fink, C. A., Fleming, T. H., Schmidt, L., Loft, A., Herzig, S., Knieß, R. A., Mayer, M. P., Bukau, B., Nawroth, P. P., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.08.007 · Cited by 43
A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease
Xie, B., Lin, F., Ullah, K., Peng, L., Ding, W. J., Dai, R., Qing, H., & Deng, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.069 · Cited by 42
An, S. S. A., Lee, B., Byun, K., Bayarsaikhan, E., Bayarsaikhan, D., Lee, J., Son, M., Moon, J., Park, H., Roshini, A., et al. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s95077 · Cited by 42
Parkinsonism-associated protein DJ-1 is a bona fide deglycase
Richarme, G., & Dairou, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.134 · Cited by 41
Renal Microvascular Injury in Diabetes: RAGE and Redox Signaling
Coughlan, M. T., Cooper, M. E., & Forbes, J. M. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.1469 · Cited by 37
Fructosamine 3-kinase-related protein and deglycation in human erythrocytes
Collard, F., Wiame, E., Bergans, N., Fortpied, J., Vertommen, D., Vanstapel, F. J. L. A., Delpierre, G., & SCHAFTINGEN, E. V. (2004) · Biochemical Journal · doi:10.1042/bj20040307 · Cited by 36
Mendler, M., Schlotterer, A., Ibrahim, Y., Kukudov, G., Fleming, T. H., Bierhaus, A., Riedinger, C., Schwenger, V., Herzig, S., Hecker, M., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3415-5 · Cited by 35
Gugliucci, A. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.05.026 · Cited by 35 · cited 1×
“Inactivation of AMPK would favor lipogenesis, insulin resistance, and hyperglycemia, all hallmarks of MetS and diabetes (Gugliucci, 2009, 2016, 2017).”
BackgroundSelf-citationGlycation potentiates neurodegeneration in models of Huntington’s disease
Miranda, H. V., Gomes, M. A., Branco‐Santos, J., Breda, C., Lázaro, D. F., Lopes, L. V., Herrera, F., Giorgini, F., & Outeiro, T. F. (2016) · Scientific Reports · doi:10.1038/srep36798 · Cited by 35
Leonardis, D., Basta, G., Mallamaci, F., Cutrupi, S., Pizzini, P., Tripepi, R., Tripepi, G. L., Caterina, R. D., & Zoccali, C. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.11.008 · Cited by 34
Dunmore, S., Alderawi, A., Nayak, A., Narshi, A., Nevill, A. M., Hellwig, A., Majebi, A., Kirkham, P., Brown, J. E. P., & Singh, B. M. (2017) · Diabetes · doi:10.2337/db17-0441 · Cited by 32
Wu, J. C., Li, X. H., Peng, Y., Wang, J. B., Tang, J. F., & Wang, Y. F. (2011) · PubMed · doi:10.3275/7856 · Cited by 27
Kalousová, M., Germanová, A., Jáchymová, M., Mestek, O., Tesař, V., & Zima, T. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1433.012 · Cited by 26 · cited 1×
“Polymorphisms associated with the glyoxalase Glo1 gene have been associated with the development of nephropathy and retinopathy in Type 2 diabetics (Gale et al., 2004; Kalousová et al., 2008; Wu et al., 2011).”
BackgroundGomes, R. A., Miranda, H. V., Silva, M. S., Graça, G., Coelho, A. V., Ferreira, A. E. N., CORDEIRO, C. A., & Freire, A. P. (2008) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2007.00337.x · Cited by 26
Song, D., Xin, N., Xie, B., Li, Y., Meng, L., LI, H.-M., Schläppi, M., & Deng, Y. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1604 · Cited by 26
Fructosamine 3-kinase and other enzymes involved in protein deglycation
SCHAFTINGEN, E. V., Delpierre, G., Collard, F., Fortpied, J., Gemayel, R., Wiame, E., & Veiga‐da‐Cunha, M. (2007) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.12.002 · Cited by 25
Common polymorphisms in the glyoxalase-1 gene and their association with pro-thrombotic factors
Gale, C. P., Futers, T. S., & Summers, L. K. M. (2004) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2004.004 · Cited by 25
Measurement of Lens Autofluorescence Can Distinguish Subjects With Diabetes From Those Without
Cahn, F., Burd, J. F., Ignotz, K., & Mishra, S. K. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813516955 · Cited by 25
Rabbani, N., & Thornalley, P. J. (2014) · Diabetes · doi:10.2337/db14-1516 · Cited by 24
Advanced glycation in diabetes, aging and age-related diseases: editorial and dedication
Monnier, V. M., & Taniguchi, N. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9704-0 · Cited by 24
Nemet, I., Strauch, C., & Monnier, V. M. (2010) · Amino Acids · doi:10.1007/s00726-010-0631-2 · Cited by 23
Sveen, K. A., Dahl‐Jørgensen, K., Stensæth, K. H., Angel, K., Seljeflot, I., Sell, D. R., Monnier, V. M., & Hanssen, K. F. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.12.011 · Cited by 23
DJ‐1 is a Parkinson's disease susceptibility gene in southern Italy
Marco, E. D., Annesi, G., Tarantino, P., Nicoletti, G., Civitelli, D., Messina, D. N., Annesi, F., Arabia, G., Salsone, M., Condino, F., et al. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01310.x · Cited by 22
Rabbani, N., & Thornalley, P. J. (2009) · Peritoneal Dialysis International · doi:10.1177/089686080902902s10 · Cited by 20 · cited 1×
“…of sensitive LC-MS/MS techniques, a more comprehensive representation of the role of the kidney in AGE control emerged, including the fate of small peptides and free adducts (Agalou et al., 2005; Rabbani and Thornalley, 2009; Rabbani et al., 2007; Thornalley, 2005b; Thornalley and Rabbani, 2009).”
MethodMechanisms Linking Aging, Diseases and Biological Age Estimation
Núñez Martínez, P. (2017) · CRC Press eBooks · doi:10.1201/9781315371382 · Cited by 18
Gugliucci, A. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.06.044 · Cited by 16 · cited 1×
“Inactivation of AMPK would favor lipogenesis, insulin resistance, and hyperglycemia, all hallmarks of MetS and diabetes (Gugliucci, 2009, 2016, 2017).”
BackgroundSelf-citationGugliucci, A. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.09.022 · Cited by 15 · cited 1×
“The latter are unstable and spontaneously decompose into inorganic phosphate and 3-deoxyglucosone, regenerating the unglycated amine (Gugliucci, 2005).”
BackgroundSelf-citationReprint of “Accumulation of modified proteins and aggregate formation in aging”
Nowotny, K., Jung, T., Grune, T., & Höhn, A. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.10.001 · Cited by 15
Bowman, M. A. H., & Schmidt, A. M. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1097-y · Cited by 13
DJR-1.2 of Caenorhabditis elegans is induced by DAF-16 in the dauer state
Lee, J., Kim, C., Kim, J., & Park, C. (2013) · Gene · doi:10.1016/j.gene.2013.04.032 · Cited by 10
Szwergold, B. S., Bunker, R. D., & Loomes, K. M. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.07.027 · Cited by 9
Methylglyoxal concentrations differ in standard and washed neonatal packed red blood cells
Kiefer, A. S., Fleming, T. H., Eckert, G. J., Poindexter, B. B., Nawroth, P. P., & Yöder, M. C. (2013) · Pediatric Research · doi:10.1038/pr.2013.243 · Cited by 8
Serratos, I. N., Castellanos, P., Pastor, N., Millán‐Pacheco, C., Colín-González, A. L., Rembao, D., Pérez‐Montfort, R., Cabrera, N., Sánchez-García, A. D. C., Gómez, I., et al. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.02.014 · Cited by 8
Flagged first, then by citations
2 of the 179 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
From discoveries in ageing research to therapeutics for healthy ageing
Campisi, J., Kapahi, P., Lithgow, G. J., Melov, S., Newman, J. C., & Verdin, E. (2019) · Nature · doi:10.1038/s41586-019-1365-2 · Cited by 1,389
Self-citationKang, Q., & Yang, C. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101799 · Cited by 1,134
“During the process, large amounts of free radicals are produced, which in turn promotes AGE formation [69].”
BackgroundAdvanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
Khalid, M., Petroianu, G. A., & Adem, A. (2022) · Biomolecules · doi:10.3390/biom12040542 · Cited by 972
“Maillard reaction generates highly reactive numerous intermediate carbonyl precursors of AGEs [20,29].”
BackgroundTwarda‐Clapa, A., Olczak, A., Białkowska, A. M., & Koziołkiewicz, M. (2022) · Cells · doi:10.3390/cells11081312 · Cited by 829
Mechanisms of Oxidative Stress in Metabolic Syndrome
Masenga, S. K., Kabwe, L. S., Chakulya, M., & Kirabo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097898 · Cited by 816
“(3) Triose phosphates produce methylglyoxal, the main precursor of advanced glycation end products (AGEs) [63].”
Background
Metadata
- Authors
- Chaudhuri, J., Bains, Y., Guha, S., Kahn, A., Hall, D., Bose, N., Gugliucci, A., & Kapahi, P.
- Affiliations
- Buck Institute for Research on Aging (US)
- Touro University California (US)
- Corresponding author
- Chaudhuri, Jyotiska
- Gugliucci, Alejandro
- Kapahi, Pankaj
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 28
- Issue
- 3
- Pages
- 337-352
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC6355252
- OpenAlex
- W2892213316
- Cited by
- 669
- References
- 179
- Citations by year
- 2026: 70 · 2025: 118 · 2024: 91 · 2023: 107 · 2022: 83 · 2021: 116 · 2020: 48 · 2019: 34 · 2018: 1
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Touro Scholar (Touro College) (submittedVersion)
- Funders
- American Federation for Aging Research
- Larry L. Hillblom Foundation
- impact circle award
- NIH (R21 AG053066, RO1 AG045835, RO1 5RO1HL113887)
- Touro University California
- NIH/NIA (T32 AG000266)
- Hillblom Foundation Postdoctoral Fellowship
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Agricultural and Biological Sciences › Food Science › Potato Plant Research
- Keywords
- advanced glycation end products, aging, metabolic disorders, AGE formation, age-related diseases, Drosophila melanogaster, Caenorhabditis elegans, invertebrate models, drug screening
- MeSH terms
- Aging, Animals, Drosophila melanogaster, Humans, Metabolic Diseases, Yeasts, Signal Transduction, Glycation End Products, Advanced, Caenorhabditis elegans, Oxidative Stress, Neurodegenerative Diseases, Models, Animal, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
